c-Abl has previously been implicated in various aspects of AD pathogenesis, ranging from aberrant APP processing and tau phosphorylation, loss of dendritic spines, and neuronal apoptosis32–34,48,49. This evidence concerns the gene MAPT and Alzheimer disease.